AZense Guideline Updates

Azense Medical Education · azense.app

AZense Guideline Updates is the companion podcast to AZense Journal Club. Each episode distills a major clinical practice guideline into a practical bedside reference for residents, hospitalists, PAs, NPs, and practicing clinicians. AI-generated voices, physician-reviewed scripts from Azense Medical Education, an Azense AI LLC educational project. For clinical education only, not individual medical advice.

43 episodes

19d ago latest

4x a week cadence

English language

▶ Play latestRSS feed Website Health Fitness Medicine Education

https://azense.app/journal-club/guidelines-podcast.xml

Episodes 44

Guideline Updates G1: Heart Failure Guideline Update
3mo ago · 20:15
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure, with 2023 ESC focused update context
Guideline Updates G2: Atrial Fibrillation Guideline Update
2mo ago · 14:11
2023 ACC/AHA/ACCP/HRS Guideline for Diagnosis and Management of Atrial Fibrillation, with 2024 ESC AF-CARE context
Guideline Updates G3: Sepsis and Septic Shock: What the 2026 Guidelines Change
2mo ago · 7:11
The Surviving Sepsis Campaign returns — 46 new statements, and the 1-hour clock just got more nuanced
Guideline Updates G4: Community-Acquired Pneumonia: Two Guidelines Walk Into a Hospital
2mo ago · 6:59
ATS 2025 update changes steroids and antibiotic duration — how to use both the 2019 and 2025 guidance together
Guideline Updates G5: COPD Exacerbations: The GOLD 2025 Framework and What Actually Changes at the Bedside
2mo ago · 6:53
From classification overhaul to dupilumab eligibility — what hospitalists need when the patient cannot breathe
Guideline Updates G6: Acute Kidney Injury: Managing What We Know While the Guidelines Catch Up
2mo ago · 6:50
KDIGO 2012 is still the official standard — a major update is in public review. How to practice confidently in the gap.
Guideline Updates G7: DKA and HHS: The 2024 Consensus Report Rewrites the Textbook
1mo ago · 7:18
Beta-hydroxybutyrate at the bedside, subcutaneous insulin for mild DKA, and HHS resolution criteria for the first time ever
Guideline Updates G8: Pulmonary Embolism Just Got Its First Major Guideline — and It Introduces a New Risk Category System
1mo ago · 11:07
The 2026 AHA/ACC PE guideline: five clinical categories, PERT escalation, outpatient PE, and CTEPH screening
Guideline Updates G9: GI Bleeding: Two Guidelines, Two Ends of the GI Tract, One Set of Principles That Save Lives
1mo ago · 6:53
ACG 2021 upper GI and 2023 lower GI guidelines — risk stratification, transfusion thresholds, endoscopy timing, and when to stop anticoagulants
Guideline Updates G10: Pneumonia with Drug-Resistant Pathogens: MRSA, Pseudomonas, and the Art of Not Over-Covering
1mo ago · 7:27
IDSA/ATS 2016 HAP/VAP guidelines, 2019 CAP risk-factor framework, and the MRSA nasal PCR that could change your next order
Guideline Updates G11: ACS Treatment Guidelines: What Hospitalists Need to Change in 2025
26d ago · 13:16
The 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline unifies STEMI and NSTE-ACS: high-sensitivity troponin pathways, radial access, complete revascularization, tailored antithrombotics, and an aggressive discharge bundle
Guideline Updates G12: Hypertension in 2025: A Universal Target, PREVENT Risk, and Race-Neutral First-Line Therapy
19d ago · 8:16
The 2025 AHA/ACC multisociety guideline moves to a universal under 130/80 target, swaps the Pooled Cohort Equations for the PREVENT calculator, removes race from drug selection, and widens primary aldosteronism screening
Guideline Updates G13: Dyslipidemia 2026: LDL Goals Return, PREVENT-ASCVD Risk, and a Once-in-a-Lifetime Lp(a)
12d ago · 6:59
The 2026 ACC/AHA multisociety guideline restores risk-stratified LDL-C goals, replaces the Pooled Cohort Equations with PREVENT-ASCVD, recommends measuring Lp(a) at least once, and formalizes ApoB and coronary calcium scoring
Guideline Updates G14: ADA Standards of Care 2025: CGM for Non-Insulin Diabetes, MASLD Treatment, and Perioperative GLP-1 Rules
5d ago · 7:17
The 2025 ADA Standards expand continuous glucose monitoring to non-insulin type 2 diabetes, add resmetirom for MASLD with fibrosis, ban DPP-4 plus GLP-1 combinations, and formalize perioperative GLP-1 guidance
Guideline Updates G15: WHO GLP-1 Obesity Guideline and AACE 2025 Obesity Update: Drug Therapy Comes of Age
just now · 7:21
The WHO issues its first guideline endorsing GLP-1 medicines for adult obesity, while AACE reframes obesity as adiposity-based chronic disease with complication-centric, cost-aware pharmacotherapy
Guideline Updates G16: GINA 2026 Strategy Report: New Acute Flowcharts, ICS-SABA at Step 1, and Depemokimab
just now · 7:43
GINA 2026 adds four acute asthma flowcharts, an ICS-SABA reliever option at Step 1, conservative oxygen and SABA dosing, single-exacerbation treatment review, and the first twice-yearly biologic
Guideline Updates G17: 2026 AHA/ASA Acute Ischemic Stroke Guideline: Tenecteplase, Dual Antiplatelet, and Large-Core Thrombectomy
just now · 8:09
The 2026 update makes tenecteplase co-equal with alteplase, replaces thrombolysis with dual antiplatelet therapy for non-disabling stroke, and expands thrombectomy to large-core infarcts
Guideline Updates G18: IDSA 2025 Complicated UTI Guideline: New Clinical Definitions and Empiric Therapy
just now · 9:25
The 2025 IDSA update defines complicated UTI by clinical findings rather than risk factors alone, retires fluoroquinolones as empiric therapy, and favors carbapenems over piperacillin-tazobactam for ESBL disease
Guideline Updates G19: Inpatient Hyperglycemia: ADA 2025 Section 16 and the Endocrine Society 2022 Guideline Aligned
just now · 10:02
Basal-bolus insulin is the standard for eating non-ICU patients, targets are 140 to 180 mg/dL for most, admission A1C drives the plan, and sliding scale alone is not adequate
Guideline Updates G20: IDSA 2024 AMR Guidance: Treating ESBL, CRE, CRAB, and DTR-Pseudomonas
just now · 10:49
The living IDSA guidance retires piperacillin-tazobactam for serious ESBL disease, makes ceftazidime-avibactam standard for KPC-type CRE, prefers sulbactam-durlobactam for CRAB, and requires novel agents for DTR-Pseudomonas
Guideline Updates G21: KDIGO 2024 CKD Guideline: When to Use SGLT2 Inhibitors
just now · 8:01
The 2024 KDIGO CKD guideline gives a tiered SGLT2 inhibitor recommendation, strong for type 2 diabetes with CKD, strong for heavy albuminuria or heart failure regardless of diabetes, and a weaker suggestion for low-albuminuria low-eGFR disease, not a blanket recommendation for all CKD
Guideline Updates G22: CHEST 2024 RBC Transfusion Guideline: Restrictive by Default, with One Big Exception
just now · 6:43
The CHEST 2024 red cell transfusion guideline makes a restrictive hemoglobin 7 to 8 strategy the strong default across critical illness and GI bleeding, but recommends against a restrictive strategy in acute coronary syndrome
Guideline Updates G23: CHEST 2025 Plasma and Platelet Guideline: Don't Top Them Off, Except for the LP
just now · 6:03
The CHEST 2025 companion guideline issues seven conditional recommendations that withhold prophylactic plasma and platelet transfusion in most ICU settings, with lumbar puncture as the one procedure that flips the default
Guideline Updates G24: IDSA 2024 Intra-Abdominal Infections, Part 1: Diagnosing the Belly Before You Treat It
just now · 6:41
The IDSA 2024 update on complicated intra-abdominal infections, Part 1, covers risk assessment, diagnostic imaging, and microbiological evaluation only; antimicrobial therapy, source control, and antifungal guidance are reserved for later parts
Guideline Updates G25: SIS 2024 Intra-Abdominal Infection Therapy: The Treatment Half of the Belly, and When to Reach for an Antifungal
just now · 9:12
The Surgical Infection Society 2024 update is the antimicrobial and antifungal therapy companion to IDSA 2024 Part 1, which covered diagnosis only; it advises against empiric antifungals in lower-risk community-acquired infection and recommends anidulafungin for higher-risk Candida intra-abdominal infection, all anchored on adequate source control

Episodes

Reading the feed…

Also on azense.app

AZense Journal Club

azense.app

64 episodes · 1mo ago

More Health shows

AZense Guideline Updates

Episodes 44

Guideline Updates G1: Heart Failure Guideline Update

Guideline Updates G2: Atrial Fibrillation Guideline Update

Guideline Updates G3: Sepsis and Septic Shock: What the 2026 Guidelines Change

Guideline Updates G4: Community-Acquired Pneumonia: Two Guidelines Walk Into a Hospital

Guideline Updates G5: COPD Exacerbations: The GOLD 2025 Framework and What Actually Changes at the Bedside

Guideline Updates G6: Acute Kidney Injury: Managing What We Know While the Guidelines Catch Up

Guideline Updates G7: DKA and HHS: The 2024 Consensus Report Rewrites the Textbook

Guideline Updates G8: Pulmonary Embolism Just Got Its First Major Guideline — and It Introduces a New Risk Category System

Guideline Updates G9: GI Bleeding: Two Guidelines, Two Ends of the GI Tract, One Set of Principles That Save Lives

Guideline Updates G10: Pneumonia with Drug-Resistant Pathogens: MRSA, Pseudomonas, and the Art of Not Over-Covering

Guideline Updates G11: ACS Treatment Guidelines: What Hospitalists Need to Change in 2025

Guideline Updates G12: Hypertension in 2025: A Universal Target, PREVENT Risk, and Race-Neutral First-Line Therapy

Guideline Updates G13: Dyslipidemia 2026: LDL Goals Return, PREVENT-ASCVD Risk, and a Once-in-a-Lifetime Lp(a)

Guideline Updates G14: ADA Standards of Care 2025: CGM for Non-Insulin Diabetes, MASLD Treatment, and Perioperative GLP-1 Rules

Guideline Updates G15: WHO GLP-1 Obesity Guideline and AACE 2025 Obesity Update: Drug Therapy Comes of Age

Guideline Updates G16: GINA 2026 Strategy Report: New Acute Flowcharts, ICS-SABA at Step 1, and Depemokimab

Guideline Updates G17: 2026 AHA/ASA Acute Ischemic Stroke Guideline: Tenecteplase, Dual Antiplatelet, and Large-Core Thrombectomy

Guideline Updates G18: IDSA 2025 Complicated UTI Guideline: New Clinical Definitions and Empiric Therapy

Guideline Updates G19: Inpatient Hyperglycemia: ADA 2025 Section 16 and the Endocrine Society 2022 Guideline Aligned

Guideline Updates G20: IDSA 2024 AMR Guidance: Treating ESBL, CRE, CRAB, and DTR-Pseudomonas

Guideline Updates G21: KDIGO 2024 CKD Guideline: When to Use SGLT2 Inhibitors

Guideline Updates G22: CHEST 2024 RBC Transfusion Guideline: Restrictive by Default, with One Big Exception

Guideline Updates G23: CHEST 2025 Plasma and Platelet Guideline: Don't Top Them Off, Except for the LP

Guideline Updates G24: IDSA 2024 Intra-Abdominal Infections, Part 1: Diagnosing the Belly Before You Treat It

Guideline Updates G25: SIS 2024 Intra-Abdominal Infection Therapy: The Treatment Half of the Belly, and When to Reach for an Antifungal

Episodes

Also on azense.app

AZense Journal Club

More Health shows

Medical News Podcast

Medicine and Science from The BMJ

The Susan Winter Show

Good Day Health

The Berne Podcast with Dr. Sam Berne

Anesthesia and Critical Care Reviews and Commentary (ACCRAC) Podcast

Episodes 44

Guideline Updates G1: Heart Failure Guideline Update

Guideline Updates G2: Atrial Fibrillation Guideline Update

Guideline Updates G3: Sepsis and Septic Shock: What the 2026 Guidelines Change

Guideline Updates G4: Community-Acquired Pneumonia: Two Guidelines Walk Into a Hospital

Guideline Updates G5: COPD Exacerbations: The GOLD 2025 Framework and What Actually Changes at the Bedside

Guideline Updates G6: Acute Kidney Injury: Managing What We Know While the Guidelines Catch Up

Guideline Updates G7: DKA and HHS: The 2024 Consensus Report Rewrites the Textbook

Guideline Updates G8: Pulmonary Embolism Just Got Its First Major Guideline — and It Introduces a New Risk Category System

Guideline Updates G9: GI Bleeding: Two Guidelines, Two Ends of the GI Tract, One Set of Principles That Save Lives

Guideline Updates G10: Pneumonia with Drug-Resistant Pathogens: MRSA, Pseudomonas, and the Art of Not Over-Covering

Guideline Updates G11: ACS Treatment Guidelines: What Hospitalists Need to Change in 2025

Guideline Updates G12: Hypertension in 2025: A Universal Target, PREVENT Risk, and Race-Neutral First-Line Therapy

Guideline Updates G13: Dyslipidemia 2026: LDL Goals Return, PREVENT-ASCVD Risk, and a Once-in-a-Lifetime Lp(a)

Guideline Updates G14: ADA Standards of Care 2025: CGM for Non-Insulin Diabetes, MASLD Treatment, and Perioperative GLP-1 Rules

Guideline Updates G15: WHO GLP-1 Obesity Guideline and AACE 2025 Obesity Update: Drug Therapy Comes of Age

Guideline Updates G16: GINA 2026 Strategy Report: New Acute Flowcharts, ICS-SABA at Step 1, and Depemokimab

Guideline Updates G17: 2026 AHA/ASA Acute Ischemic Stroke Guideline: Tenecteplase, Dual Antiplatelet, and Large-Core Thrombectomy

Guideline Updates G18: IDSA 2025 Complicated UTI Guideline: New Clinical Definitions and Empiric Therapy

Guideline Updates G19: Inpatient Hyperglycemia: ADA 2025 Section 16 and the Endocrine Society 2022 Guideline Aligned

Guideline Updates G20: IDSA 2024 AMR Guidance: Treating ESBL, CRE, CRAB, and DTR-Pseudomonas

Guideline Updates G21: KDIGO 2024 CKD Guideline: When to Use SGLT2 Inhibitors

Guideline Updates G22: CHEST 2024 RBC Transfusion Guideline: Restrictive by Default, with One Big Exception

Guideline Updates G23: CHEST 2025 Plasma and Platelet Guideline: Don't Top Them Off, Except for the LP

Guideline Updates G24: IDSA 2024 Intra-Abdominal Infections, Part 1: Diagnosing the Belly Before You Treat It

Guideline Updates G25: SIS 2024 Intra-Abdominal Infection Therapy: The Treatment Half of the Belly, and When to Reach for an Antifungal